Vanderbilt Institute for Therapeutic Advances launches to redefine drug discovery and biomedical innovation

Vanderbilt University has announced the Vanderbilt Institute for Therapeutic Advances as part of its bold Discovery Vanderbilt initiative, establishing a pioneering hub to catalyze next-generation breakthroughs in therapeutic discovery.  

VITA, directed by Craig Lindsley, William K. Warren, Jr. Professor of Medicine and executive director of the Warren Center for Neuroscience Drug Discovery, builds on Vanderbilt’s proven leadership in drug discovery to create a new model: one that fuses basic research with systems biology, genomics and artificial intelligence to drive high-impact innovation.  


Read more: https://news.vanderbilt.edu/2026/01/21/vanderbilt-institute-for-therapeutic-advances-launches-to-redefine-drug-discovery-and-biomedical-innovation/

Next
Next

Vanderbilt honors 2025 Master Innovators who drive breakthrough research and commercial impact